Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 0.259
-4.18 %
$ 2.59 M
Market Cap
-0.04
P/E
Price Target
Average
--100.00%
Revenue Forecast
Estimate
47.80%
EBIT
Estimate
--19.52%
Net Income
Estimate
20.25%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Petros Pharmaceuticals, Inc.
PTPI has no price targets from Wall Street.
REVENUE FORECAST
Revenue Forecast Chart PTPI
EBIT FORECAST
EBIT Forecast Chart PTPI
NET INCOME FORECAST
Net Income Chart PTPI